Conference Coverage
Conference Coverage
Living donor liver transplants on rise for most urgent need
Patient survival appears to be comparable to deceased donor liver transplantation.
Conference Coverage
World falls short on HBV, HCV elimination targets
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...
Conference Coverage
NAFLD patients with diabetes have higher fibrosis progression rate
Patients with type 2 diabetes had about a 2-year faster progression to fibrosis.
Conference Coverage
Resmetirom reduces liver, CV risk factors in NASH with cirrhosis
“I do think it could be one of the drugs that really improves outcomes for patients with NASH.”
Conference Coverage
Noninvasive tests may provide prognostic value in NAFLD
Fibrosis biomarkers were significantly predictive of event-free survival probability.
Conference Coverage
Low-carb diet aids weight loss in liver transplant recipients with obesity
The diet didn’t negatively affect serum lipids or renal function.
Conference Coverage
Endoscopic severity score helps guide treatment in immune-mediated colitis
The scoring system could assist with accurate severity assessment and choice of medical treatment.
Conference Coverage
Guselkumab induction improves moderate to severe active UC at week 12
The drug was statistically superior to the placebo across all key endpoints in phase 2b study, regardless of patient response or intolerance to...
Conference Coverage
Dupilumab improves eosinophilic esophagitis up to 24 weeks
The drug received FDA approval for EoE treatment earlier in 2022.
Conference Coverage
NAFLD progresses to cirrhosis in young and old at similar rate
Risk factors for NAFLD vary with age, but all patients experience similar progression of advanced disease once it develops.